FXH or IHI or XHE

Key Takeaways

• FXH employs a smart beta AlphaDEX strategy across the broad U.S. healthcare sector with 76 holdings and a 0.61% expense ratio, offering diversified exposure beyond devices.
• IHI provides market-cap weighted access to 47 U.S. medical device companies at a 0.38% expense ratio, with heavy concentration in top holdings like ISRG and ABT.
• XHE delivers modified equal-weight exposure to 68 health care equipment and supplies firms via the S&P Select Industry Index, at the lowest 0.35% expense ratio, minimizing mega-cap dominance.
• All three focus on healthcare but differ structurally: FXH (broad/smart beta), IHI (devices/market-cap), XHE (equipment/equal-weight), impacting concentration risk and volatility.
• XHE and IHI exhibit higher sensitivity to medical device trends, while FXH's broader tilt provides relative stability in recent market cycles.
• Cost efficiency favors XHE, diversification depth suits FXH, and liquidity is strongest in IHI.

Introduction

FXH, IHI, and XHE offer investors targeted pathways into the resilient U.S. healthcare sector, particularly amid ongoing innovation in medical technology and aging demographics. While all provide healthcare exposure, they diverge strategically: FXH uses a smart beta approach across the full sector, IHI focuses on market-cap weighted medical devices, and XHE applies modified equal-weighting to health care equipment. This comparison is timely as capital rotates toward defensive growth themes, with medical devices facing procedural volume pressures but long-term tailwinds from AI integration and chronic disease prevalence. Investors can select based on desired breadth, concentration tolerance, and cost sensitivity in this ETF comparison.

First Trust Health Care AlphaDEX® Fund (FXH) Overview

The First Trust Health Care AlphaDEX® Fund (FXH) tracks the StrataQuant® Health Care Index, a modified equal-dollar weighted benchmark that selects stocks from the Russell 1000® Index's healthcare segment using AlphaDEX® methodology. This smart beta strategy ranks companies on growth (e.g., momentum, value factors) and weights them tiered equally to seek alpha relative to traditional caps. FXH holds approximately 76 stocks, with top holdings including OGN (Organon & Co., ~3.8%), HUM (Humana Inc., ~3.0%), ELV (Elevance Health Inc., ~2.8%), MOH (Molina Healthcare Inc., ~2.5%), and CI (Cigna Group, ~2.4%). Sector allocation is predominantly healthcare (~100%), blending providers, biotech, and equipment. The expense ratio is 0.61%, with quarterly rebalancing. As a passive smart beta ETF, FXH emphasizes factor-driven outperformance over pure indexing.

iShares U.S. Medical Devices ETF (IHI) Overview

The iShares U.S. Medical Devices ETF (IHI) tracks the Dow Jones U.S. Select Medical Equipment Index, measuring U.S. equities in medical device manufacturing and distribution (e.g., scanners, pacemakers, prosthetics). This market-cap weighted passive ETF holds 47 stocks, featuring high concentration in leaders: ISRG (Intuitive Surgical Inc., ~16.7%), ABT (Abbott Laboratories, ~15.7%), SYK (Stryker Corp., ~10.5%), EW (Edwards Lifesciences Corp., ~5.0%), and IDXX (IDEXX Laboratories Inc., ~5.0%). Top 10 comprise ~75% of assets, with 100% healthcare allocation. Expense ratio stands at 0.38%, with quarterly rebalancing typical for the index. IHI suits pure-play device exposure but carries elevated single-stock risk.

State Street® SPDR® S&P® Health Care Equipment ETF (XHE) Overview

The State Street® SPDR® S&P® Health Care Equipment ETF (XHE) tracks the S&P Health Care Equipment Select Industry Index, a modified equal-weighted benchmark from the S&P Total Market Index's equipment and supplies segment. Holding 68 stocks, it promotes unconcentrated exposure across large-, mid-, and small-caps. Top holdings include STAA (STAAR Surgical Co., ~2.8%), NVCR (NovoCure Ltd., ~2.6%), GKOS (Glaukos Corp., ~2.4%), AXGN (Axogen Inc., ~2.3%), and AVNS (Avanos Medical Inc., ~2.2%). Sector breakdown: Health Care Equipment (~75%), Health Care Supplies (~25%). Expense ratio is 0.35%, with the index rebalanced quarterly. XHE's structure reduces mega-cap bias for balanced risk.

Industry and Thematic Landscape

The healthcare equipment and medical devices subsector benefits from aging populations, chronic disease growth, and technological advances like AI diagnostics and minimally invasive procedures. Macro drivers include steady U.S. GDP growth supporting elective volumes, though inflation and interest rates pressure capital spending. Capital flows have shifted toward defensive healthcare amid market volatility, with ETF inflows rising in late 2025 cycles. Regulatory shifts, including FDA scrutiny on AI/software devices and potential tariffs on imports, add hurdles alongside supply chain reshoring efforts. Geopolitical tensions impact raw materials, while M&A activity surges (e.g., $97B medtech deals in 2025) signals consolidation. Sector risks encompass procedural deferrals and reimbursement pressures, balanced by innovation tailwinds.

Performance and Positioning Comparison

In recent months, all three ETFs have navigated healthcare rotation, with IHI and XHE showing sharper drawdowns (~15% quarterly) due to device-specific softness in procedural volumes and valuation resets. FXH, with broader exposure including stable providers, exhibited milder declines (~8-10%) and lower relative volatility (beta ~0.88 vs. IHI's 0.94 and XHE's 1.30). XHE's equal-weighting amplified small/mid-cap sensitivity to macro tightening, leading to higher drawdowns but potential upside in rebounds. IHI's mega-cap tilt offered trend consistency but concentration risk amplified losses. FXH's smart beta favored momentum stability. Differences stem from FXH's diversification vs. the device purity of IHI/XHE, positioning the former for risk-adjusted resilience and the latter for thematic beta plays.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization (market cap), technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening, empowering data-driven decisions across asset classes like healthcare ETFs.

Tickeron AI Verdict

Tickeron’s AI favors XHE with moderate conviction (~55% probability edge) due to its lowest expense ratio (0.35%), superior diversification (68 equal-ish holdings reducing concentration risk), and balanced risk-adjusted positioning in equipment/supplies. While FXH offers broader stability and IHI superior liquidity, XHE's structure aligns best with current momentum in mid/small-caps amid sector rebound potential.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations